猪肺炎支原体168弱毒株P46-P65融合蛋白的免疫原性
发布时间：2018-12-10 17:17
【摘要】：根据猪肺炎支原体168(Mycoplasma hyopneumoniae 168,Mhp168)弱毒株p46和p65基因序列设计特异性引物,进行PCR扩增并构建表达载体pET-28a-p46,pET-28a-p65以及pET-28a-p46-p65。以表达载体pET-28a-p46和pET-28a-p46-p65为模板,将其中p46基因3个TGA密码子突变为TGG。原核表达并纯化的蛋白与佐剂以体积比1∶1乳化后免疫小鼠,通过酶联免疫吸附反应(ELISA)测定小鼠血清的抗体效价。分别选取抗体效价较高的小鼠进行攻毒试验。经间接ELISA试验证明单蛋白P46、P65以及融合蛋白P46-P65的血清效价分别为:1∶1 280000,1∶128 000和1∶2 560 000;攻毒试验证明,P46、P65单蛋白和P46-P65融合蛋白疫苗的保护率分别可达82%,78%和98%。融合蛋白P46-P65具有良好的免疫原性,并且要优于单蛋白P46和P65的免疫原性。
[Abstract]:According to the sequence of p46 and p65 genes of attenuated strain p46 and p65 of Mycoplasma pneumoniae 168 (Mycoplasma hyopneumoniae 168 Mhp168), specific primers were designed for PCR amplification and construction of expression vector pET-28a-p46,pET-28a-p65 and pET-28a-p46-p65.. Using the expression vectors pET-28a-p46 and pET-28a-p46-p65 as templates, three TGA codon of p46 gene were mutated into TGG.. Mice were immunized with prokaryotic protein and adjuvant after emulsified at 1:1. The antibody titers of mouse serum were determined by Elisa (ELISA). Mice with high antibody titer were selected to test the antivirus. The results of indirect ELISA test showed that the serum titers of single protein P46, P65 and fusion protein P46-P65 were 1:1 2800001: 128000 and 1:2 560000, respectively. The protective rates of P46 P65 and P46-P65 fusion protein vaccine were up to 82% and 98%, respectively. The fusion protein P46-P65 has good immunogenicity and is superior to that of P46 and p65.
【作者单位】： 河北师范大学生命科学学院;
【基金】：河北省科技支撑计划资助项目(13226603D)
【分类号】：S852.62
[Abstract]:According to the sequence of p46 and p65 genes of attenuated strain p46 and p65 of Mycoplasma pneumoniae 168 (Mycoplasma hyopneumoniae 168 Mhp168), specific primers were designed for PCR amplification and construction of expression vector pET-28a-p46,pET-28a-p65 and pET-28a-p46-p65.. Using the expression vectors pET-28a-p46 and pET-28a-p46-p65 as templates, three TGA codon of p46 gene were mutated into TGG.. Mice were immunized with prokaryotic protein and adjuvant after emulsified at 1:1. The antibody titers of mouse serum were determined by Elisa (ELISA). Mice with high antibody titer were selected to test the antivirus. The results of indirect ELISA test showed that the serum titers of single protein P46, P65 and fusion protein P46-P65 were 1:1 2800001: 128000 and 1:2 560000, respectively. The protective rates of P46 P65 and P46-P65 fusion protein vaccine were up to 82% and 98%, respectively. The fusion protein P46-P65 has good immunogenicity and is superior to that of P46 and p65.
【作者单位】： 河北师范大学生命科学学院;
【基金】：河北省科技支撑计划资助项目(13226603D)
【分类号】：S852.62
【相似文献】
相关期刊论文 前10条
1 王璋瑜;;蛋白设计实验室公司买下融合蛋白技术实用权[J];生物技术通报;1990年10期
2 张毅,屈贤铭,杨胜利;融合蛋白基因工程应用及研究[J];生物工程进展;2000年03期
3 杨林,李国清,黄葆英,王全忠,龙綮新,王s阏，
本文编号：2370937
本文链接：https://www.wllwen.com/yixuelunwen/dongwuyixue/2370937.html
